Cargando…

SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups

Liver is unlikely the key organ driving mortality in coronavirus disease 2019 (COVID-19) however, liver function tests (LFTs) abnormalities are widely observed mostly in moderate and severe cases. According to this review, the overall prevalence of abnormal LFTs in COVID-19 patients ranges from 2.5%...

Descripción completa

Detalles Bibliográficos
Autor principal:	Liatsos, George D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167898/ https://www.ncbi.nlm.nih.gov/pubmed/37179584 http://dx.doi.org/10.3748/wjg.v29.i16.2397

Ejemplares similares

SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications
por: Abou Hassan, Ossama K., et al.
Publicado: (2021)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection
por: Nayagam, Jeremy S, et al.
Publicado: (2021)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

Incidence and Severity of SARS-CoV-2 Infections in People With Primary Ciliary Dyskinesia
por: Pedersen, Eva S. L., et al.
Publicado: (2023)

SARS-CoV-2: Is the liver merely a bystander to severe disease?
por: Bangash, Mansoor N., et al.
Publicado: (2020)

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection
por: Crudele, Lucilla, et al.
Publicado: (2022)

POS-861 INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY WITH SARS-CoV-2 INFECTION IN DISADVANTAGED POPULATION
por: NAVA-VARGAS, M.G., et al.
Publicado: (2022)

SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease
por: Choaib, Ali, et al.
Publicado: (2022)

Predictors of Liver Injury in Hospitalized Patients with SARS-CoV-2 Infection
por: Mihai, Nicoleta, et al.
Publicado: (2022)

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients
por: Sadaf, Rabiah, et al.
Publicado: (2023)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003
por: Tseng, Wen-Pin, et al.
Publicado: (2021)

Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
por: Rosazza, Chiara, et al.
Publicado: (2023)

SARS-CoV-2 Infection and the Liver
por: Morgan, Katie, et al.
Publicado: (2020)

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020)

Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe
Publicado: (2023)

Acute Myocardial Injury During SARS-CoV-2 Pneumonia and Long-term Prognosis
por: Sanz, Francisco, et al.
Publicado: (2022)

Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020–2021
por: den Boogert, Elisabeth Maria, et al.
Publicado: (2022)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Yin, Shiyu, et al.
Publicado: (2020)

No increased injury incidence in the German Bundesliga after the SARS-CoV-2 virus lockdown
por: Krutsch, Werner, et al.
Publicado: (2021)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

Systematic analysis of acute liver injury during SARS-CoV-2 infection
por: Debes, Jose D., et al.
Publicado: (2020)

Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan
por: Jang, Tyng-Yuan
Publicado: (2022)

Incidence and Outcome of Coinfections with SARS-CoV-2 and Rhinovirus
por: Le Glass, Elisabeth, et al.
Publicado: (2021)

Parallel dynamics in the yield of universal SARS-CoV-2 admission screening and population incidence
por: Schreiber, Peter W., et al.
Publicado: (2023)

Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2022)

Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas
por: Shi, Yu-ling, et al.
Publicado: (2005)

Liver dysfunction and SARS-CoV-2 infection
por: Gracia-Ramos, Abraham Edgar, et al.
Publicado: (2021)

SARS-CoV-2 infection and liver involvement
por: Luo, Mingjia, et al.
Publicado: (2022)

Effect of SARS-CoV-2 infection on the liver
por: Sanyaolu, Adekunle, et al.
Publicado: (2023)

Autoimmune liver diseases and SARS-CoV-2
por: Sgamato, Costantino, et al.
Publicado: (2023)

SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population
por: Maldonado-Cabrera, Anahí, et al.
Publicado: (2023)

Severe Neurologic Complications of SARS-CoV-2
por: Sisniega, Daniella C., et al.
Publicado: (2021)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

Relationship of SARS-CoV-2 Pandemic with Blood Groups
por: Yanardag Acik, Didar, et al.
Publicado: (2021)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Mechanism of SARS-CoV-2 Invasion into the Liver and Hepatic Injury in Patients with COVID-19
por: Zhang, XiaoTian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k5vnbi4bejor292vbpr9ie1dfm